NuFund Venture Group

NuFund Venture Group, established in 1997, is an angel investment group based in San Diego, California. They focus on investing in early-stage technology and life science companies, with a particular interest in software, hardware, cleantech, mobile, biotechnology, medical devices, and digital health sectors.

Caitlin Wege

Past President

8 past transactions

Resolute Science

Venture Round in 2025
Resolute Science is a biotechnology company focused on developing innovative medicines for aggressive and hard-to-treat solid tumors. It employs a proprietary technology platform, MAC-TACs (Macrophage Targeted Conjugates), to create a new class of biomarker-driven, first-in-class synthetic molecules. These molecules target tumor-associated macrophages, potentially enhancing efficacy and safety compared to current treatments. Resolute aims to cure a wide range of solid tumors, offering hope to patients with challenging conditions.

Alt Sports Data

Seed Round in 2024
Alt Sports Data specializes in providing official data from emerging and non-mainstream sports to the gaming and wagering industry. The company leverages its proprietary data and odds to connect alternative sports with various stakeholders, including sports leagues, technology platforms, data providers, regulated sportsbook operators, athletes, and other market participants. By distributing this data, Alt Sports Data enhances the content ecosystem and extends the market and audience for these niche sports.

Vasa Therapeutics

Seed Round in 2024
Vasa Therapeutics is a privately held, preclinical-stage biopharmaceutical company based in Encinitas, California. The company focuses on developing therapies for various vascular diseases, including heart failure, peripheral artery disease, and sarcopenia. Vasa Therapeutics employs a comprehensive platform for drug discovery, allowing for the identification and development of small molecule or peptide therapeutics. This in-house testing funnel enables healthcare professionals to efficiently evaluate potential treatments, aiming to improve outcomes for patients suffering from vascular conditions.

Kneevoice

Seed Round in 2023
Kneevoice is a company focused on advancing knee health and wellness through its innovative digital patellofemoral audio-arthrography system. Founded in 2015 and based in Santa Monica, California, the company integrates a sophisticated sound acquisition system with cloud-based machine-learning algorithms. This technology allows for prompt and efficient diagnostic accuracy, which was previously attainable only through non-dynamic, non-specific, or invasive testing methods. By utilizing wearable devices, Kneevoice enables patients to monitor and maintain their knee health effectively.

PrivacyHawk

Seed Round in 2023
PrivacyHawk is a consumer privacy platform that empowers individuals to manage their personal data effectively. The company provides an automated solution for opting out, unsubscribing, and deleting personal information from numerous databases that may exploit clients' data. By streamlining these processes, PrivacyHawk helps users reduce their digital footprint and enhance their privacy, thereby lowering the risks associated with scams, spam, and identity theft. The platform focuses on enabling individuals to regain control over their private information, promoting a safer online experience.

Cooler Heads

Venture Round in 2023
Cooler Heads is a company that specializes in developing a portable scalp cooling system aimed at helping chemotherapy patients manage the side effects of their treatment. Their flagship product, Amma™, is designed to cool the scalp during chemotherapy sessions, reducing the likelihood of hair loss. By offering this solution, Cooler Heads empowers cancer patients with more control over their appearance and overall well-being during a challenging time, thereby improving their mental health and recovery process.

Duo Oncology

Seed Round in 2023
Duo Oncology is a biotechnology company focused on developing innovative nanoparticle technology designed to penetrate established tumors, particularly targeting hard-to-treat cancers such as pancreatic cancer and bile duct cancer. By collaborating closely with leading university scientists and medical oncologists, Duo Oncology aims to redefine treatment outcomes through a novel monotherapy approach that enhances patient care. The company's research is supported by a network of established research organizations, enabling efficient and rapid development of its products. With a commitment to advancing immunotherapy and precision medicine, Duo Oncology seeks to improve recovery times and overall treatment efficacy for patients facing challenging diagnoses.

KeepWOL

Pre Seed Round in 2022
KeepWOL is a developer of a talent development platform that focuses on enhancing team collaboration and fostering inclusion across remote, hybrid, and in-person teams. The company's software offers a comprehensive library of content, facilitation training, and ongoing support designed to facilitate cultural transformation and team building. By providing insightful learning and development resources, KeepWOL enables organizations to create guided immersive experiences that promote employee development and engagement. The platform combines the human element with data and artificial intelligence to deliver real-time feedback and actionable insights, helping teams identify critical growth opportunities and improve overall organizational health. Through its innovative approach, KeepWOL aims to strengthen team dynamics and enhance execution within organizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.